Figure 2From: Improvement in multiple dimensions of fatigue in patients with fibromyalgia treated with duloxetine: secondary analysis of a randomized, placebo-controlled trialReduction (mean changes) from baseline in depressed mood, anxiety, 'bothered by sleep difficulties', and musculoskeletal stiffness. Comparisons versus placebo: *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001. DLX, duloxetine; PLA, placebo.Back to article page